3.6(top 10%)
impact factor
7.4K(top 5%)
papers
199.4K(top 2%)
citations
145(top 2%)
h-index
3.7(top 10%)
impact factor
8.4K
all documents
207.9K
doc citations
213(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s diseaseNeurochemistry International2004782
2Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathologyNeurochemistry International2004702
3Invited review c-Fos as a transcription factor: a stressful (re)view from a functional mapNeurochemistry International1998620
4A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytesNeurochemistry International2009605
5Handbook of Chemical NeuroanatomyNeurochemistry International1986603
6Melatonin receptors: Localization, molecular pharmacology and physiological significanceNeurochemistry International1994582
7The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?Neurochemistry International2016565
8GABA TRANSPORTER HETEROGENEITY: PHARMACOLOGY AND CELLULAR LOCALIZATIONNeurochemistry International1996561
9Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptorsNeurochemistry International2001554
10The role of glutamate transporters in neurodegenerative diseases and potential opportunities for interventionNeurochemistry International2007521
11Post-translational modifications of tau protein: Implications for Alzheimer's diseaseNeurochemistry International2011517
12Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targetsNeurochemistry International2002512
13Melatonin stimulates brain glutathione peroxidase activityNeurochemistry International1995499
14Invited Review Free radicals and the pathobiology of brain dopamine systemsNeurochemistry International1998469
15Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercuryNeurochemistry International2013439
16Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's diseaseNeurochemistry International2009438
17Peripheral benzodiazepine receptors and mitochondrial functionNeurochemistry International2002417
18Role of astrocytes in the clearance of excess extracellular potassiumNeurochemistry International2000396
19Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injuryNeurochemistry International2006393
20Structure–activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivativesNeurochemistry International2006390
21Metal dyshomeostasis and oxidative stress in Alzheimer’s diseaseNeurochemistry International2013376
22Tachykinin receptor types: Classification and membrane signalling mechanismsNeurochemistry International1991348
23Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic painNeurochemistry International2004339
24Role of oxidative stress in epileptic seizuresNeurochemistry International2011335
25Mechanisms of action of valproate: a commentatoryNeurochemistry International2000334
26Transmitter deficits in Alzheimer's diseaseNeurochemistry International1985333
27Regular exercise improves cognitive function and decreases oxidative damage in rat brainNeurochemistry International2001319
28Gangliosides in the nervous systemNeurochemistry International1983317
29Egr transcription factors in the nervous systemNeurochemistry International1997317
30Glutamine synthetase in brain: effect of ammoniaNeurochemistry International2002307
31Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomesNeurochemistry International1990303
32Mitochondrial contributions to tissue damage in strokeNeurochemistry International2002300
33Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development—A study of molecular formsNeurochemistry International1992298
34Mechanisms of glutamate release from astrocytesNeurochemistry International2008296
35Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serineNeurochemistry International2013296
36Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injuryNeurochemistry International2017290
37Cholinergic systems in mammalian brain identified with antibodies against choline acetyltransferaseNeurochemistry International1984282
38Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injuryNeurochemistry International2013280
39Structure and subunit composition of GABAA receptorsNeurochemistry International1999278
40Mitophagy in neurodegeneration and agingNeurochemistry International2017272
41Neurotransmitters as developmental signalsNeurochemistry International1991271
42The function of metallothioneinNeurochemistry International1995269
43Role of actin cytoskeleton in dendritic spine morphogenesisNeurochemistry International2007260
44Ferroptosis and cell death mechanisms in Parkinson's diseaseNeurochemistry International2017260
45Dopamine receptors in brain and peripheryNeurochemistry International1987253
46The functions of UCH-L1 and its relation to neurodegenerative diseasesNeurochemistry International2007250
47Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s diseaseNeurochemistry International2013250
48Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytesNeurochemistry International2002247
49Reactive oxygen species and ischemic cerebrovascular diseaseNeurochemistry International2012244
50Localization and function of dopamine in the adult vertebrate retinaNeurochemistry International1992242